Literature DB >> 3364944

Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

E J Goldstein1, D M Citron, G A Richwald.   

Abstract

The in vitro susceptibility of human isolates of Pasteurella multocida to oral antimicrobial agents from our current study and from a review of the literature suggests that dicloxacillin (oxacillin), erythromycin, clindamycin, cephalexin, cefaclor, and cefadroxil should not be used for empiric therapy of animal bite wounds. Agents that were consistently active against P. multocida were penicillin, ampicillin, amoxicillin-clavulanic acid, tetracycline, minocycline, chloramphenicol, trimethoprim-sulfamethoxazole, and cefuroxime. Possible reasons for the confusion regarding the activity of oral cephalosporins are addressed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364944      PMCID: PMC172137          DOI: 10.1128/AAC.32.2.213

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.

Authors:  G J Noel; D W Teele
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

2.  Pasteurella multocida infection after animal bites.

Authors:  R W Goldstein; G L Goodhart; J E Moore
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

3.  Antimicrobial drug susceptibility of certain bacterial pathogens from dogs and cats.

Authors:  H Hariharan; D A Barnum
Journal:  Can Vet J       Date:  1974-04       Impact factor: 1.008

4.  Local Pasteurella multocida infections.

Authors:  L G Hawkins
Journal:  J Bone Joint Surg Am       Date:  1969-03       Impact factor: 5.284

5.  Antibiotic susceptibilities of human isolates of Pasteurella multocida.

Authors:  D L Stevens; J W Higbee; T R Oberhofer; E D Everett
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  Review of 59 patients hospitalized with animal bites.

Authors:  H M Feder; J D Shanley; J A Barbera
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129

Review 7.  Pasteurella multocida infections. Report of 34 cases and review of the literature.

Authors:  D J Weber; J S Wolfson; M N Swartz; D C Hooper
Journal:  Medicine (Baltimore)       Date:  1984-05       Impact factor: 1.889

8.  Pasteurella multocida infection in the hand.

Authors:  G L Lucas; D H Bartlett
Journal:  Plast Reconstr Surg       Date:  1981-01       Impact factor: 4.730

9.  Characteristics of 20 human Pasteurella isolates from animal bite wounds.

Authors:  W L Dibb; A Digranes
Journal:  Acta Pathol Microbiol Scand B       Date:  1981-06

10.  Prophylactic oxacillin in dog bite wounds.

Authors:  R M Elenbaas; W K McNabney; W A Robinson
Journal:  Ann Emerg Med       Date:  1982-05       Impact factor: 5.721

View more
  13 in total

1.  Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Authors:  Diane M Citron; Yumi A Warren; Helen T Fernandez; Maurice A Goldstein; Kerin L Tyrrell; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolates.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Kerin L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

5.  In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida.

Authors:  E Holst; J Rollof; H Miörner
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  Pasteurella multocida septicemia and subsequent Pasteurella dagmatis septicemia in a diabetic patient.

Authors:  C J Fajfar-Whetstone; L Coleman; D R Biggs; B C Fox
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; C A Nesbit; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

9.  Pasteurella multocida involved in respiratory disease of wild chimpanzees.

Authors:  Sophie Köndgen; Michaela Leider; Felix Lankester; Astrid Bethe; Antina Lübke-Becker; Fabian H Leendertz; Christa Ewers
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Infective Exacerbation of Pasteurella multocida.

Authors:  Mayumi Hamada; Noha Elshimy; Hatem Abusriwil
Journal:  Case Rep Infect Dis       Date:  2016-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.